Literature DB >> 30898956

Rare case of catastrophic antiphospholipid syndrome with spontaneous intracranial haemorrhage.

Anju Adhikari1, Mohammad Muhsin Chisti2, Sanjog Bastola1, Ojbindra Kc1.   

Abstract

Catastrophic antiphospholipid syndrome (CAPS) is a rare but severe form of antiphospholipid syndrome (APS). The syndrome manifests itself as a rapidly progressive multiorgan failure that is believed to be caused by widespread micro-thrombosis. Seldom does bleeding comanifest with thrombosis. We present a patient with APS who presented with nausea, vomiting and fatigue, and rapidly progressed into multiorgan failure before being diagnosed with CAPS. The clinical course was complicated by an atraumatic intracranial haemorrhage which demanded discontinuation of anticoagulation. The patient was treated with high dose steroid, intravenous immunoglobulin, followed by weekly rituximab infusion. Although the trigger for CAPS was not obvious during her hospital stay, she was diagnosed with acute cytomegalovirus (CMV) infection soon after discharge. In this case report, we explore the differential diagnoses of CAPS, investigate the possibility of CMV infection as a potential trigger, present the therapeutic challenges of anticoagulation and discuss the emerging use of rituximab. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  biological agents; haematology (drugs and medicines); haematology (incl blood transfusion); immunology; rheumatology

Mesh:

Substances:

Year:  2019        PMID: 30898956      PMCID: PMC6453383          DOI: 10.1136/bcr-2018-227171

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.

Authors:  Mark A Crowther; Jeff S Ginsberg; Jim Julian; Judah Denburg; Jack Hirsh; James Douketis; Carl Laskin; Paul Fortin; David Anderson; Clive Kearon; Ann Clarke; William Geerts; Melissa Forgie; David Green; Lorrie Costantini; Wendy Yacura; Sarah Wilson; Michael Gent; Michael J Kovacs
Journal:  N Engl J Med       Date:  2003-09-18       Impact factor: 91.245

Review 2.  Antiphospholipid antibodies and infections.

Authors:  R A Asherson; R Cervera
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

3.  Catastrophic antiphospholipid syndrome treated with rituximab: A case report.

Authors:  Atalay Doğru; Yunus Ugan; Mehmet Şahin; Nermin Karahan; Şevket Ercan Tunç
Journal:  Eur J Rheumatol       Date:  2017-06-01

Review 4.  Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome.

Authors:  Ronald A Asherson
Journal:  Immunobiology       Date:  2005-10-20       Impact factor: 3.144

5.  Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies.

Authors:  G Ruiz-Irastorza; M J Cuadrado; I Ruiz-Arruza; R Brey; M Crowther; R Derksen; D Erkan; S Krilis; S Machin; V Pengo; S Pierangeli; M Tektonidou; M Khamashta
Journal:  Lupus       Date:  2011-02       Impact factor: 2.911

6.  Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome.

Authors:  Miri Blank; Ilan Krause; Mati Fridkin; Nathan Keller; Juri Kopolovic; Iris Goldberg; Ana Tobar; Yehuda Shoenfeld
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 7.  Hughes syndrome, the antiphospholipid syndrome: a new chapter in neurology.

Authors:  Giovanni Sanna; Maria Laura Bertolaccini; Graham R V Hughes
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

8.  Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients.

Authors:  Silvia Bucciarelli; Gerard Espinosa; Ricard Cervera; Doruk Erkan; José A Gómez-Puerta; Manuel Ramos-Casals; Josep Font; Ronald A Asherson
Journal:  Arthritis Rheum       Date:  2006-08

Review 9.  The challenge of bleeding in antiphospholipid antibody-positive patients.

Authors:  Giulia Pazzola; Stéphane Zuily; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2015-02       Impact factor: 4.592

10.  Transient antiphospholipid syndrome associated with primary cytomegalovirus infection: a case report and literature review.

Authors:  Tsuyoshi Nakayama; Mitsuteru Akahoshi; Kensuke Irino; Yasutaka Kimoto; Yojiro Arinobu; Hiroaki Niiro; Hiroshi Tsukamoto; Takahiko Horiuchi; Koichi Akashi
Journal:  Case Rep Rheumatol       Date:  2014-12-08
View more
  1 in total

Review 1.  COVID-19, Antiphospholipid Antibodies, and Catastrophic Antiphospholipid Syndrome: A Possible Association?

Authors:  Georges El Hasbani; Ali T Taher; Ali Jawad; Imad Uthman
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2020-12-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.